Bausch Health Companies (BHC) Cash & Current Investments (2009 - 2026)

Bausch Health Companies has reported Cash & Current Investments for 18 years, with the latest figure at $1.8 billion in Q2 2026.

• Quarterly Cash & Current Investments rose 5.45% year-over-year to $1.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 5.45% YoY) and the FY2025 annual result came in at $1.3 billion, up 10.32% from the prior year.
• Cash & Current Investments advanced to $1.8 billion in Q2 2026 per BHC's latest filing, from $1.3 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $2.5 billion in Q1 2022 and troughed at $497.0 million in Q3 2022.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments sank 78.41% in 2023, then jumped 179.78% in 2025.
• Over 5 years, Cash & Current Investments stood at $591.0 million in 2022, then soared by 62.77% to $962.0 million in 2023, then grew by 24.84% to $1.2 billion in 2024, then rose by 10.32% to $1.3 billion in 2025, then jumped by 38.72% to $1.8 billion in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.8 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.